Cargando…
Antibody waning after immunosuppressive chemotherapy and immunomodulators, re-immunization considerations in pediatric patients with malignancy and chronic immune thrombocytopenic purpura
INTRODUCTION: Immunosuppressive chemotherapy increase the risk of vaccine-preventable infectious diseases in children; nevertheless, chemotherapy may result in delay or miss updated immunization schedules. The predictable antibody waning after incomplete primary immunization series may be intensifie...
Autores principales: | Abdolkarimi, Babak, Amanati, Ali, Molavi Vardanjani, Hossein, Jamshidi, Safura, Tabaeian, Seid Amir Pasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335959/ https://www.ncbi.nlm.nih.gov/pubmed/35902837 http://dx.doi.org/10.1186/s12879-022-07647-1 |
Ejemplares similares
-
Practical considerations for the management of immune thrombocytopenic purpura
por: Fillitz, Michael, et al.
Publicado: (2021) -
Immune thrombocytopenic purpura
por: Zainal, Abir, et al.
Publicado: (2019) -
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Tuberculosis presenting as immune thrombocytopenic purpura
por: Ozkalemkas, Fahir, et al.
Publicado: (2004) -
Disseminated tuberculosis with immune thrombocytopenic purpura
por: Dagaonkar, Rucha S., et al.
Publicado: (2012)